Cyclooxygenase (COX)-2 expression in intestinal epithelial cells is associated with colorectal carcinogenesis. COX-2 expression is induced by numerous growth factors and gastrointestinal hormones through multiple protein kinase cascades. Here, the role of mitogen activated protein kinases (MAPKs) and small GTPases in COX-2 expression was investigated. Anisomycin and sorbitol induced COX-2 expression in nontransformed, intestinal epithelial IEC-18 cells. Both anisomycin and sorbitol activated p38
Introduction
Prostaglandins (PGs) play a fundamental role in a broad range of physiological processes [1] [2] [3] [4] [5] . PGs, which are produced from arachidonic acid by cyclooxygenases (COX, EC 1.14.99.1), are implicated in pathological processes including cancer [6] [7] [8] . COX-2 is rapidly induced in response to pro-inflammatory cytokines, tumor promoters, and growth factors and is over-expressed in cancers of the colon [9] [10] [11] [12] . Inhibition of COX-2 activity by nonsteroidal anti-inflammatory drugs has been associated with chemoprotective effects on colon cancer [4] .
Cellular proliferation, lineage-specific differentiation, migration, and cell death of epithelial cells of the intestinal mucosa are a tightly regulated process that is modulated by broad spectrum of regulatory peptides [13 -15] , but the signal transduction pathways involved remain incompletely understood. The non-transformed epithelial IEC-18 cells derived from rat intestinal crypt [16] has been a useful model to examine intestinal epithelial migration, differentiation, proliferation and COX-2 expression [17 -21] . These cells are undifferentiated as judged by morphologic and functional criteria, they resemble stem cells and thus may serve as a model to study the crypt stem cell [22] . The importance of examining this compartment is highlighted by reports suggesting that colorectal adenoma arise from mutant cells from the crypt cell compartment involving aberrant COX-2 expression [20, 21] .
Recently, we showed agonist-induced prostaglandin production in IEC-18 cells by Angiotensin (Ang) II and EGF through distinct mitogen-activated protein kinase (MAPK) signaling cascades [23] . The three MAPK subfamilies, including p42/44-MAPK/extracellular regulated kinase-1 and-2 (ERK1/2), p38
MAPK , and c-Jun N-terminal kinase (JNK) [24] , have been implicated in the induction of COX-2 expression by G-protein coupled receptors [25] . Specifically, we have shown in IEC-18 cells, COX-2 induction by Ang II and EGF through activation of p38 MAPK and ERK signaling pathways, respectively, that converged onto a cis-acting ATF/CRE transcriptional element on the proximal COX-2 promoter [23] . The specific transcription factors that mediate MAP kinase induced COX-2 expression in IEC-18 cells have not been elucidated. Additionally, agonist-dependent COX-2 induction required Rho family, small GTPases but it is unclear whether MAP kinases are upstream or downstream of Rho GTPases.
In this study, we activate MAP kinase signaling using anisomycin and sorbitol to elucidate signaling pathways that lead to COX-2 expression in the absence of cell surface receptor activation [26 -30] . We report, for the first time, that anisomycin and sorbitol, individually, directly induce COX-2 expression in IEC-18 cells via p38 MAPK and CREB phosphorylation. Inhibition of Rho family GTPases by Clostridium difficile toxin B blocked both Ang II-and sorbitoldependent COX-2 expression and phosphorylation of p38 MAPK and CREB. Toxin B did not block anisomycindependent phosphorylation of either p38 MAPK or CREB, or induction of COX-2 expression, indicating that Rho family GTPases are up-stream of p38 MAPK / CREB signaling and down-stream of the AT 1 receptor and osmotic stress.
Materials and methods

Reagents
Anisomycin, sorbitol, angiotensin II, PD98059 and U0126 were purchased from Sigma (St. Louis, MO). Clostridium difficile Toxin B, SB202190, PD169316 and JNK inhibitor II (SP600125) were purchased from EMD Biosciences, Inc. (San Diego, CA). IEC-18 cell line was purchased from ATCC (Manassas, VA). Stock cultures of these cells were maintained in Dulbecco's modified Eagle's medium (DMEM, Sigma) supplemented with 10% fetal bovine serum (FBS) and 1% antibiotics-antimycotic (Invitrogen, Carlsbad, CA) in a humidified 10% CO 2 atmosphere at 37 -C.
Isolation of RNA and Taqman analysis
Total RNA was harvested using Trizol reagent (Invitrogen) according to manufacturer's instructions. The relative levels of COX-2 mRNA to GAPDH mRNA was measured using Real-time RT-PCR, Taqman Assay (Applied Biosystems, Inc., Foster City, CA). Rat COX-2 Taqman primer set (Fig. 1A) was synthesized by MWG Biotech (High Point, NC). GAPDH mRNA was measured using the rodent GAPDH Taqman primer set (Applied Biosystems, Inc.). Dual reaction mixtures were made using the Reverse Transcriptase qPCR master mix (Eurogentec North America, Inc., San Diego, CA), 25 ng of sample RNA and either the COX-2 or the GAPDH primer-probe sets. Assays were run on an ABI 7700 using the settings of 30 m at 48 -C; 10 m at 95 -C; and (40X) 15 s at 95 -C, 60 s at 60 -C at either the Human Genetics Core Facility, UCLA or the Division of Pulmonary and Critical Care Medicine, UCLA. The change in COX-2 mRNA relative to GAPDH mRNA was calculated from the measured C T value using the formula, fold RNA induction = 2
ÀDDCT where
RNA interference
Smartpool siRNA targeted to rat CREB (NM 031017) was purchased from Dharmacon (Lafayette, CO). IEC-18 cells were transfected with either CREB specific or random siRNA using a multiporator (Eppendorf, Westbury, NY). Cells were resuspended in hypoosmolar buffer (Eppendorf) at 2 Â 10 6 cells/ml and aliquoted into sterile tubes (0.4 ml). After 15 m, siRNA was added and the cells transferred to a 2-mm electrocuvette. The cells were treated with 320 V, 100 As, n = 2 and then allowed to recover for 5 m. The cells were plated onto 35 mm dishes with complete media (2 ml).
Western blot analysis
Confluent IEC-18 cells grown on 35-mm dishes were incubated in Opti-MEM (18 h) prior to stimulation with agonists. The cells were washed twice (PBS) prior to lysis with 2Â LDS-NuPAGE sample buffer (Invitrogen, Carlsbad, CA). Equal volumes of protein extract were run on 4-12% Nu-PAGE acrylamide gels (Invitrogen) and then electroblotted onto PVDF paper (Millipore, Bedford, MA). Membranes were blocked in 5% nonfat milk in Tris-buffered saline (TBS) for 1 h. Membranes were incubated overnight with antibodies, 1:1000 dilution in TBS, 0.05% Tween-20 (TBST). The membrane was washed 3 times using TBST and then incubated with Horseradish peroxidase-conjugated IgG antibody (1:5000; Amersham Biosciences, Piscataway, NJ) for 1 h. Immunoreactive bands were detected using Enhanced Chemiluminance (Amersham Biosciences). Antibodies specific for ERK 1/2, phospho-ERK, p38
MAPK , phospho-p38 MAPK , phospho-JNK, phospho-CREB and CREB were purchased from Cell Signaling (Beverly, MA).
p38
MAPK kinase assay Confluent, serum starved IEC-18 cells on 100 mm dishes were treated with anisomycin. At the indicated times, protein kinase activity of p38 MAPK was measured using the p38 MAPK Assay kit (#9820) from Cell Signaling.
Statistical analysis
Data were analyzed using Student's t-distribution using average values and the associated standard errors. A comparative P-value of less than 0.05 was considered significant.
Results
Stress induces COX-2 mRNA expression in IEC-18 cells
The Taqman primer/probe sets (Fig. 1A ) that were used for measuring relative amounts of COX-2 and GAPDH mRNA were validated by a series of Taqman assays using serial dilutions of total RNA from IEC-18 cells (Fig. 1B) . The efficiency of PCR was greater than 99% for both the Increasing amounts of anisomycin (0.01, 0.1, 1.0, 10 Ag/ml) were added to cells. After 1 h, total RNA was purified and the relative expression level of COX-2 mRNA was measured. Anisomycin (10 Ag/ml) (E) or sorbitol (0.2 M) (F) were added to cells. RNA was purified at 0, 0.5, 1, 2, 4 and 6 h.
COX-2 and GAPDH primer/probe sets. Next, the use of GAPDH as the standard to measure the relative changes in COX-2 mRNA levels was validated. Treatment of cells with anisomycin did not significantly change GAPDH C T levels (Fig. 1C) .
IEC-18 cells were stressed with anisomycin which resulted in a dose-dependent induction of COX-2 mRNA (EC 50 = 0.029 T 0.008 Ag/ml) (Fig. 1D) . Maximal COX-2 mRNA induction levels achieved a plateau at 10 Ag/ml of anisomycin. Next, cells were treated with anisomycin for up to 6 h. There was a rapid rise in the relative COX-2 mRNA levels in the first hour of treatment with anisomycin, followed by a plateau (Fig. 1E) . COX-2 mRNA levels peaked at 4 h and then decreased at 6 h.
Cellular stress from hyperosmotic shock also induced COX-2 expression. COX-2 mRNA levels increased in sorbitol (0.2 M) treated IEC-18 cells (Fig. 1F ). COX-2 mRNA levels reached a maximum after 4 h of sorbitol treatment and then significantly decreased by 6 h.
Anisomycin and Sorbitol stimulates activation of p38
MAPK and phosphorylation of CREB Anisomycin induced p38 MAPK activity within 5 min that reached a maximum by 10 min (Fig. 2A) . The p38 MAPK activity remained elevated up to 30 min. The phosphorylation of p38 MAPK was well correlated to the level of induced kinase activity (Fig. 2B) . Phospho-p38 MAPK was detected 5 min after treatment with anisomycin that then reached maximal levels after 10 min.
Anisomycin also induced phosphorylation of ERK and JNK (Fig. 2B) . Both ERK and JNK showed delayed phosphorylation by anisomycin occurring 10 min after stimulation with phosphorylation levels increasing up to 30 min. The level of phosphorylation of ERK and JNK by anisomycin was significantly lower compared to cells that were treated with Ang II or EGF (data not shown).
Phosphorylation of CREB which binds to the CRE/ATF cis-acting element in the proximal region of the COX-2 promoter can induce COX-2 expression [9] . Anisomycin induced CREB phosphorylation in IEC-18 cells within 10 min and remained elevated for up to 30 min (Fig. 3B) . The time course of CREB phosphorylation suggests that this is mediated by protein kinase cascades involving p38 MAPK and not through either ERK or JNK.
MAP kinases are also activated by hyperosmotic stress induced by sorbitol in IEC-18 cells in a time dependent manner (Fig. 2C) . Phosphorylation of p38 MAPK was evident by 2.5 min after sorbitol treatment, reaching a maximum by 5 min and then remaining elevated up to 30 min. ERK phosphorylation was maximal at 10 min and remained elevated up to 30 min. In contrast to cells treated with anisomycin, sorbitol did not significantly increase JNK phosphorylation levels in treated cells. Phosphorylation of CREB at serine residue 133 was maximal at 10 min after sorbitol treatment and remained elevated up to 30 min.
Stress-induced COX-2 expression and CREB phosphorylation is mediated by p38 MAPK
In order to determine the specific MAP kinase signaling cascade that is utilized by anisomycin for induction of COX-2, cells were pretreated with MAP kinase selective inhibitors. The inhibitors to ERK phosphorylation, PD98059 and U0126, caused a decrease in anisomycindependent COX-2 induction by 24% and 51%, respectively (Fig. 3A) . In striking contrast, there were significant decreases (92% and 85%) in the level of COX-2 induction by anisomycin in cells pretreated with the p38 MAPK selective inhibitors, SB202190 and PD169316, respectively. The JNK selective inhibitor, SP600125 (20 AM), did not significantly decrease anisomycin-induced COX-2 expression in IEC-18 cells (data not shown).
In order to determine whether anisomycin-dependent CREB phosphorylation is mediated by p38 MAPK or ERK, cells were pretreated with selective inhibitors of ERK phosphorylation (PD98059 and U0126) or the selective p38 MAPK inhibitors, SB202190 and PD169316 prior to stimulation. Anisomycin strongly induced the phosphorylation of p38 MAPK in cells that were pretreated with either PD98059 or U0126 (Fig. 3B) . Anisomycin-dependent phosphorylation of ERK was blocked by PD98059 and U0126. Correspondingly, there was a relatively high level of anisomycin-dependent phospho-CREB in cells pretreated with PD98059 or U0126. Anisomycin-dependent phosphorylation of p38 MAPK was significantly decreased in cells that were pretreated with SB202190 or PD169316, presumably by inhibition of p38 MAPK autophosphorylation. This correlated with inhibition of CREB phosphorylation. Since ERK phosphorylation was not affected by pretreatment with SB202190 or PD169316, this indicates that p38 MAPK and not ERK mediate anisomycin-dependent phosphorylation of CREB.
Because sorbitol mediated hyperosmotic stress induces MAP kinase phosphorylation and COX-2 induction in IEC-18 cells, we wanted to determine whether this is mediated by p38 MAPK or other MAP kinases. Cells pretreated with either SB202190 or PD169316, showed a respective 87% Fig. 3 . Anisomycin-dependent COX-2 expression is mediated by p38 MAPK and CREB phosphorylation. (A) Confluent, serum-starved cells were either untreated or pretreated (1 h) with the selective MEK inhibitors, PD98059 (10 AM) or U0126 (1 AM), the selective p38 MAPK inhibitors, SB202190 (10 AM) or PD169316 (10 AM), or with the GTPase inhibitor, C. difficile toxin B (25 ng/ml, 18 h) prior to stimulation with anisomycin (10 Ag/ml). After 1 h, total RNA was purified and the relative expression level of COX-2 mRNA was measured. (B) Confluent, serum-starved cells were either untreated or pretreated PD98059, U0126, SB202190, PD169316, or with the GTPase inhibitor, C. difficile toxin B prior to stimulation with anisomycin (10 Ag/ml, 10 min). Western blot analysis was done using antibodies specific against phospho-p38 MAPK , phospho-ERK, ERK and phospho-CREB. Relative COX-2 mRNA expression levels were measured in cells that were either untreated or treated with either C. difficile toxin B, SB202190 or PD169139 prior to stimulation with (C) sorbitol (0.2 M, 1 h) or (F) Ang II (100 nM, 1 h). Western blot of protein extracts from serum starved cells that were untreated or treated with either C. difficile toxin B, SB202190 or PD169139 prior to stimulation with either (D) sorbitol (0.2 M, 10 min) or (E) Ang II (100 nM, 10 min) using antibodies to phospho-p38 MAPK and phospho-CREB.
and 79% reduction in sorbitol-dependent COX-2 expression (Fig. 3C) . Pretreatment of cells with either PD98059 or U0126 resulted in just a modest decrease in sorbitoldependent COX-2 expression (data not shown). SB202190 and PD169316 inhibited both sorbitol-induced phosphorylation of p38 MAPK and CREB (Fig. 3D) .
3.4. Anisomycin but not Sorbitol-induced phosphorylation of p38 MAPK and CREB is independent of Small GTPases Small GTPases are required for Ang II-and EGFdependent COX-2 expression in IEC-18 cells [23] . In order to determine whether anisomycin has the same requirement for COX-2 expression, cells were treated with Clostridium difficile toxin B. Signaling by small GTPases was effectively blocked in IEC-18 cells by overnight incubation by toxin B [23] , which inactivates Rho, Rac and Cdc42 by glucosylation [31] . Anisomycin-dependent COX-2 mRNA induction levels increased by 9% in cells that were treated with toxin B (Fig.  3A) . Conversely, inhibition of small GTPases by toxin B reduced COX-2 expression by sorbitol by 75% (Fig. 3C) . Small GTPases were not required for anisomycin-induced phosphorylation of p38 MAPK and CREB (Fig. 3B) . However, sorbitol-induced phosphorylation of p38 MAPK and CREB was inhibited in cells treated with toxin B (Fig. 3D) . Correspondingly, Ang II-dependent phosphorylation of p38 MAPK and CREB was inhibited by toxin B (Fig. 3E) . Inhibition of p38 MAPK activity by SB202190 or PD169316 also decreased p38 MAPK phosphorylation and blocked phosphorylation of CREB. Ang II was not able to induce COX-2 mRNA expression in IEC-18 cells that were pretreated with toxin B, SB202190 or PD169316 (Fig. 3F) . This indicates that small GTPase activity is not required for anisomycin-induced COX-2 expression via p38 MAPK and CREB. While sorbitoland Ang II-dependent COX-2 expression requires both small GTPase and p38 MAPK activities.
CREB-dependent COX-2 expression by Anisomycin
In order to determine whether COX-2 expression by anisomycin is mediated by CREB, IEC-18 cells were transfected with CREB specific siRNA. CREB protein expression levels decreased in cells that were transfected with increasing amounts of CREB siRNA (Fig. 4A) . Cells that were either untreated or transfected with random sequence siRNA showed higher expression levels of CREB. Inhibition of CREB expression resulted in a 66% decrease in anisomycin-dependent COX-2 expression (Fig. 4B) . These results indicate that CREB mediates COX-2 induction by anisomycin through p38 MAPK In IEC-18 cells.
Discussion
In intestinal crypt-like IEC-18 cells, Ang II induces COX-2 expression through p38
MAPK and transcription factors that bind to the ATF/CRE cis-acting promoter element via the AT 1 receptor [23] . COX-2 expression by Ang II is also dependent on small GTPase activity but its role in the signaling cascade from the AT 1 receptor to the COX-2 promoter has not been elucidated. Because cell surface receptors activate multiple kinase cascades that have the potential for cross talk, the precise signaling pathway(s) responsible for induction of COX-2 remains unclear. Therefore, it is important to bypass cell surface receptors and activate specific signaling pathways that act proximally to the transcription factors that are involved with COX-2 expression.
In this study, we used anisomycin and sorbitol to stimulate COX-2 mRNA expression independent of cell surface receptor agonists. Anisomycin, which inhibits protein translation by binding to 60S ribosomal subunits and blocking peptide bond formation [32] initiates a cellular stress response that results in activation of protein kinases. Anisomycin-induced p38 MAPK activation was the predominant signaling pathway leading to COX-2 expression. Specifically, p38
MAPK was the initial MAPK that was phosphorylated in response to anisomycin, with ERK and JNK phosphorylation occurring later. CREB phosphorylation was apparent after p38 MAPK phosphorylation but before the bulk of ERK/JNK phosphorylation. Inhibition of p38 MAPK activity blocked both anisomycin-dependent phosphorylation of CREB and induction of COX-2 mRNA. Reduction of CREB protein levels significantly inhibited COX-2 mRNA induction by anisomycin. This demonstrates that CREB plays a direct role in COX-2 expression by anisomycin and that eventhough there have been multiple studies establishing anisomycin induction of MAP kinase signaling, leading to gene expression [33] , this is the first demonstration of COX-2 induction by anisomycin and highlights the importance of the p38 MAPK / CREB signaling cascade for COX-2 expression in intestinal epithelial cells.
We next examined the hypothesis that Rho GTPases lie between the AT 1 receptor and the p38 MAPK pathway leading to COX-2 induction. Our results show that inhibition of small GTPases by toxin B did not inhibit anisomycindependent phosphorylation of p38 MAPK and CREB, or induction of COX-2 mRNA expression. In striking contrast, treatment with toxin B prevented sorbitol and AT 1 receptor mediated COX-2 mRNA induction and phosphorylation of p38 MAPK and CREB. Sorbitol causes a hyperosmotic stress response to cell shrinkage that involves the actin cytoskeleton and small GTPases [34] . Recent studies have identified an osmosensing scaffold protein (OSM) which binds to cortical actin structures together with Rac and MEKK3/MKK3 as a kinase signaling complex [35] . This signaling complex is able to phosphorylate p38 MAPK in response to hyperosmotic shock. We have already shown that Ang II activates small GTPases and p38 MAPK in IEC-18 cells [23] . It is possible that the signaling cascades that are initiated by Ang II and sorbitol converge at small GTPases and the actin cytoskeleton, leading to COX-2 expression via p38 MAPK and CREB. Our results indicating that small GTPase activity is not required for p38 MAPK /CREB mediated COX-2 mRNA induction by anisomycin demonstrates that activation of p38 MAPK is sufficient for COX-2 expression. In addition, it clearly places small GTPases between the AT 1 receptor and activation of p38 MAPK /CREB in IEC-18 cells.
The p38 MAPK signaling cascade has emerged as a significant pathway for COX-2 expression in both normal and transformed cells involving both transcriptional and post-transcriptional mechanisms. We have shown in IEC-18 cells that Ang II induces transcription of the COX-2 promoter by signaling through p38 MAPK and transcription factors that bind to the CRE/ATF cisacting element [23] . In addition, post-transcriptional regulation of COX-2 mRNA stability is regulated by MAP kinases including p38 MAPK through RNA binding proteins that interact with AUUUA targets in the 3V-untranslated region [36] . The functional significance of p38 MAPK signaling has been highlighted by the recent report showing p38 MAPK regulation of COX-2 expression in human mammary epithelial cells, and it's activation in premalignant tissue [37] . It is possible that aberrant p38 MAPK activity could have a role in carcinogenesis particularly as an inducer for COX-2 expression. Future studies elucidating both upstream and downstream pathways of p38
MAPK and COX-2 may provide further insights into early carcinogenesis and identify novel approaches for chemopreventation.
